Drugs

Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future
pp. 747-756(10)
Author: Allen T.M.

Factors in Improved Survival from Paediatric Cancer
pp. 757-765(9)
Author: Taub J.W.

Is There a Future for Antiarrhythmic Drug Therapy?
pp. 767-781(15)
Authors: Guerra P.G.; Talajic M.; Roy D.; Dubuc M.; Thibault B.; Nattel S.

Topical NSAIDs for Musculoskeletal Conditions: A Review Of The Literature
pp. 783-799(17)
Authors: Vaile J.H.; Davis P.

Current Recommendations for the Prophylaxis and Treatment of Rabies
pp. 801-809(9)
Authors: Dreesen D.W.; Hanlon C.A.

A Practical Guide to the Management and Prevention of Migraine
pp. 811-824(14)
Authors: Diener H-C.; Kaube H.; Limmroth V.

Dienogest
pp. 825-833(9)
Authors: Foster R.H.; Wilde M.I.

Dienogest: A Viewpoint by Herbert Kuhl
pp. 834-835(2)
Author: Kuhl H.

Dienogest: A Viewpoint by J. Spona
pp. 834-835(2)
Author: Spona J.

Fixed Combination Verapamil SR/Trandolapril
pp. 837-844(8)
Authors: Dooley M.; Goa K.L.

Fixed Combination Verapamil SR/Trandolapril: A Viewpoint by Vincent DeQuattro
pp. 845-846(2)
Author: DeQuattro V.

Fixed Combination Verapamil SR/Trandolapril: A Viewpoint by J.F. Hansen
pp. 845-846(2)
Author: Hansen J.F.

Candesartan Cilexetil: A Review of its Use in Essential Hypertension
pp. 847-869(23)
Authors: McClellan K.J.; Goa K.L.

Trandolapril: An Update of its Pharmacology and Therapeutic Use in Cardiovascular Disorders
pp. 871-893(23)
Authors: Peters D.C.; Noble S.; Plosker G.L.

Ofloxacin: A Reappraisal of its Use in the Management of Genitourinary Tract Infections
pp. 895-928(34)
Authors: Onrust S.V.; Lamb H.M.; Barman Balfour J.A.

Urapidil: A Reappraisal of its Use in the Management of Hypertension
pp. 929-955(27)
Authors: Dooley M.; Goa K.L.